BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37659991)

  • 1. Dynamic Treatment Regimes Using Bayesian Additive Regression Trees for Censored Outcomes.
    Li X; Logan BR; Hossain SMF; Moodie EEM
    Lifetime Data Anal; 2024 Jan; 30(1):181-212. PubMed ID: 37659991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bayesian inference for optimal dynamic treatment regimes in practice.
    Rodriguez Duque D; Moodie EEM; Stephens DA
    Int J Biostat; 2023 Nov; 19(2):309-331. PubMed ID: 37192544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decision making and uncertainty quantification for individualized treatments using Bayesian Additive Regression Trees.
    Logan BR; Sparapani R; McCulloch RE; Laud PW
    Stat Methods Med Res; 2019 Apr; 28(4):1079-1093. PubMed ID: 29254443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating heterogeneous survival treatment effect in observational data using machine learning.
    Hu L; Ji J; Li F
    Stat Med; 2021 Sep; 40(21):4691-4713. PubMed ID: 34114252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Semiparametric analysis of clustered interval-censored survival data using soft Bayesian additive regression trees (SBART).
    Basak P; Linero A; Sinha D; Lipsitz S
    Biometrics; 2022 Sep; 78(3):880-893. PubMed ID: 33864633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Bayesian Machine Learning Approach for Optimizing Dynamic Treatment Regimes.
    Murray TA; Yuan Y; Thall PF
    J Am Stat Assoc; 2018; 113(523):1255-1267. PubMed ID: 30739965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonparametric machine learning for precision medicine with longitudinal clinical trials and Bayesian additive regression trees with mixed models.
    Spanbauer C; Sparapani R
    Stat Med; 2021 May; 40(11):2665-2691. PubMed ID: 33751659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonparametric failure time: Time-to-event machine learning with heteroskedastic Bayesian additive regression trees and low information omnibus Dirichlet process mixtures.
    Sparapani RA; Logan BR; Maiers MJ; Laud PW; McCulloch RE
    Biometrics; 2023 Dec; 79(4):3023-3037. PubMed ID: 36932826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bayesian Additive Regression Trees (BART) with covariate adjusted borrowing in subgroup analyses.
    Pan J; Bunn V; Hupf B; Lin J
    J Biopharm Stat; 2022 Jul; 32(4):613-626. PubMed ID: 35737650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating heterogeneous survival treatment effects of lung cancer screening approaches: A causal machine learning analysis.
    Hu L; Lin JY; Sigel K; Kale M
    Ann Epidemiol; 2021 Oct; 62():36-42. PubMed ID: 34157399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New Statistical Learning Methods for Estimating Optimal Dynamic Treatment Regimes.
    Zhao YQ; Zeng D; Laber EB; Kosorok MR
    J Am Stat Assoc; 2015; 110(510):583-598. PubMed ID: 26236062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adaptive contrast weighted learning for multi-stage multi-treatment decision-making.
    Tao Y; Wang L
    Biometrics; 2017 Mar; 73(1):145-155. PubMed ID: 27213913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new method for clustered survival data: Estimation of treatment effect heterogeneity and variable selection.
    Hu L
    Biom J; 2024 Jan; 66(1):e2200178. PubMed ID: 38072661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonparametric survival analysis using Bayesian Additive Regression Trees (BART).
    Sparapani RA; Logan BR; McCulloch RE; Laud PW
    Stat Med; 2016 Jul; 35(16):2741-53. PubMed ID: 26854022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Semiparametric Bayesian inference for optimal dynamic treatment regimes via dynamic marginal structural models.
    Rodriguez Duque D; Stephens DA; Moodie EEM; Klein MB
    Biostatistics; 2023 Jul; 24(3):708-727. PubMed ID: 35385100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of Bayesian and frequentist approaches to incorporating clinical and biological information for the prediction of response to standardized pediatric colitis therapy.
    Wang Z; Nie J; Song X; Denson LA; Hyams JS
    PLoS One; 2024; 19(3):e0295814. PubMed ID: 38446811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imputation-based Q-learning for optimizing dynamic treatment regimes with right-censored survival outcome.
    Lyu L; Cheng Y; Wahed AS
    Biometrics; 2023 Dec; 79(4):3676-3689. PubMed ID: 37129942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bayesian additive regression trees and the General BART model.
    Tan YV; Roy J
    Stat Med; 2019 Nov; 38(25):5048-5069. PubMed ID: 31460678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of censoring on learning Bayesian networks in survival modelling.
    Stajduhar I; Dalbelo-Basić B; Bogunović N
    Artif Intell Med; 2009 Nov; 47(3):199-217. PubMed ID: 19833488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonparametric competing risks analysis using Bayesian Additive Regression Trees.
    Sparapani R; Logan BR; McCulloch RE; Laud PW
    Stat Methods Med Res; 2020 Jan; 29(1):57-77. PubMed ID: 30612519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.